Isomaltitol is a sugar alcohol produced by the hydrogenation of isomaltose, a disaccharide composed of glucose and fructose. It is approximately 60% as sweet as sucrose but contains less than half the calories. Isomaltitol is commonly used as a sugar substitute in food products due to its low glycemic index and its ability to provide a pleasant mouthfeel. It is also known to have a low cariogenic potential, meaning it does not contribute to tooth decay. Research on isomaltitol focuses on its potential applications in food science, its impact on gut health, and its potential as a prebiotic ingredient. '
6-O-alpha-D-glucopyranosyl-D-glucitol : A glycosyl alditol consisting of alpha-D-glucopyranose and D-glucitol residues joined in sequence by a (1->6)-glycosidic bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 94169 |
| CHEBI ID | 152898 |
| SCHEMBL ID | 371449 |
| MeSH ID | M0051824 |
| Synonym |
|---|
| isomaltitol |
| 534-73-6 |
| isomaltitol, >=98% (hplc) |
| alpha-d-glcp-(1->6)-d-glucitol |
| 6-o-alpha-d-glucopyranosyl-d-glucitol |
| CHEBI:152898 |
| alpha-d-glcp-(1->6)-d-glc-oh |
| (2s,3r,4r,5r)-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol |
| einecs 208-605-3 |
| d-glucitol, 6-o-alpha-d-glucopyranosyl- |
| unii-qfa026jzx2 |
| qfa026jzx2 , |
| d-glucitol, 6-o-.alpha.-d-glucopyranosyl- |
| glucosylsorbitol [mi] |
| 6-o-.alpha.-d-glucopyranosyl-d-glucitol |
| 6-o-.alpha.-glucopyranosyl-d-sorbitol |
| AKOS025311412 |
| 6-o-alpha-d-glucopyranosyl-d-sorbitol |
| SERLAGPUMNYUCK-YJOKQAJESA-N |
| SCHEMBL371449 |
| DTXSID3074571 |
| D81759 |
| (2s,3r,4r,5r)-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol |
| (2s,3r,4r,5r)-6-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)hexane-1,2,3,4,5-pentaol |
| CS-0077793 |
| Q27287232 |
| HY-W032970 |
| 6-o--d-glucopyranosyl-d-glucitol |
| Excerpt | Reference | Relevance |
|---|---|---|
| "For the sake of metabolic insight into the fate of the sugar substitute Palatinit, its two components D-glucosyl-alpha (1 leads to 1)-D-mannitol and D-glucosyl-alpha (1 leads to 6)-D-glucitol [D-glucosyl-alpha-(1 leads to 6)-D-sorbitol] were assayed for glucose bioavailability by the procedure of Karimzadegan et al." | ( Bioavailability of glucose from Palatinit. Ziesenitz, SC, 1983) | 0.27 |
| Item | Process | Frequency |
|---|---|---|
| Barritas de cereales | core-ingredient | 7 |
| Barritas | core-ingredient | 7 |
| Snacks dulces | core-ingredient | 7 |
| Botanas | core-ingredient | 7 |
| Cereales para el desayuno | core-ingredient | 4 |
| Cereales y derivados | core-ingredient | 4 |
| Cereales y patatas | core-ingredient | 4 |
| Desayunos | core-ingredient | 4 |
| Alimentos de origen vegetal | core-ingredient | 4 |
| Alimentos y bebidas de origen vegetal | core-ingredient | 4 |
| en:Low calorie cereal bar | core-ingredient | 3 |
| Alfajores | core-ingredient | 2 |
| en:Crunchy mueslis | core-ingredient | 2 |
| en:Mueslis with nuts | core-ingredient | 2 |
| en:Cereals with nuts | core-ingredient | 2 |
| Muesli | core-ingredient | 2 |
| Copos de cereales | core-ingredient | 1 |
| Copos | core-ingredient | 1 |
| Barritas de cereales con chocolate | core-ingredient | 1 |
| Class | Description |
|---|---|
| O-acyl carbohydrate | A carbohydrate derivative in which the hydrogen atom of at least one alcoholic hydroxy group of a carbohydrate has been replaced by an acyl substituent. |
| glycosyl alditol | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (42.49) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||